A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection

Molecular and Cellular Proteomics

Volumn 13, Issue 12, 2014, Pages 3250-3269

  Dave, Keyur A ^a   Norris, Emma L ^a   Bukreyev, Alexander A ^b,c   Headlam, Madeleine J ^a   Buchholz, Ursula J ^b   Singh, Toshna ^a   Collins, Peter L ^b   Gorman, Jeffrey J ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2 INTERFERON; BETA1 INTERFERON; CELL PROTEIN; GAMMA INTERFERON; INTERLEUKIN 29; PROTEOME; TRYPSIN; TUMOR NECROSIS FACTOR; VIRUS PROTEIN; CELL EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; PEPTIDE FRAGMENT; TUMOR NECROSIS FACTOR ALPHA;

A549 CELL LINE; ARTICLE; BIOINFORMATICS; CELL FRACTIONATION; CELL LYSATE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG ALVEOLUS EPITHELIUM CELL; NANOANALYSIS; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; REFERENCE VALUE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VIRUS IMMUNITY; WESTERN BLOTTING; WHOLE CELL; CELL LINE; CHEMISTRY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; METABOLISM; PROTEIN DEGRADATION; RESPIRATORY TRACT MUCOSA; SIGNAL TRANSDUCTION; VIROLOGY;

HUMAN RESPIRATORY SYNCYTIAL VIRUS;

CELL EXTRACTS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERONS; NF-KAPPA B P52 SUBUNIT; PEPTIDE FRAGMENTS; PROTEOLYSIS; PROTEOME; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 84928239611     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.041129     Document Type: Article

References (81)

1. Collins, P. L., Chanock, R. M., and Murphy, B. R. (2001) "Respiratory Syncytial Virus," In: Knipe, D. M., Howley, P. M., Griffin, D. E., Lamb, R. A., Martin, M. A., Roizman, B., and Straus, S. E., eds. Fields Virology, Fourth Ed., pp. 1443-1485, Lippincott-Raven Publishers, Philadelphia.
2. Collins, P. L., and Crowe, J. E. J. (2007) "Respiratory Syncytial Virus and Metapneumovirus," In: Knipe, D. M., Howley, P. M., Griffin, D. E., Lamb, R. A., Martin, M. A., Roizman, B., and Straus, S. E., eds. Fields Virology, 5 Ed., pp. 1601-1646, Lippincott-Raven Publishers, Philadelphia.
3. Collins, P. L., and Graham, B. S. (2008) Viral and host factors in human respiratory syncytial virus pathogenesis. J. Virol. 82, 2040-2055
4. Hall, C. B. (1994) Prospects for a respiratory syncytial virus vaccine. Science 265, 1393-1394
5. Levin, M. J. (1994) Treatment and prevention options for respiratory syncytial virus infections. J. Pediatr. 124, S22-S27
6. Collins, P. L., and Murphy, B. R. (2005) New generation live vaccines against human respiratory syncytial virus designed by reverse genetics. Proc. Am. Thorac. Soc. 2, 166-173
7. Collins, P. L., Whitehead, S. S., Bukreyev, A., Fearns, R., Teng, M. N., Juhasz, K., Chanock, R. M., and Murphy, B. R. (1999) Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. Adv. Virus Res. 54, 423-451
8. Karron, R. A., Wright, P. F., Belshe, R. B., Thumar, B., Casey, R., Newman, F., Polack, F. P., Randolph, V. B., Deatly, A., Hackell, J., Gruber, W., Murphy, B. R., and Collins, P. L. (2005) Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J. Infect. Dis. 191, 1093-1104
9. Luongo, C., Yang, L., Winter, C. C., Spann, K. M., Murphy, B. R., Collins, P. L., and Buchholz, U. J. (2009) Codon stabilization analysis of the "248" temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates. Vaccine 27, 5667-5676
10. van Drunen Littel-van den Hurk, S., Mapletoft, J. W., Arsic, N., and Kovacs-Nolan, J. (2007) Immunopathology of RSV infection: prospects for developing vaccines without this complication. Rev. Med. Virol. 17, 5-34
11. Afghani, B., Ngo, T., Leu, S. Y., Wu, F. L., Cecilio, M., Aron-Johnson, P., Zeitany, R., Sills, J., and Amin, A. (2006) The effect of an interventional program on adherence to the american academy of pediatrics guidelines for palivizumab prophylaxis. Pediatr. Infect. Dis. J. 25, 1019-1024
12. Mejias, A., and Ramilo, O. (2008) Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants. Biologics 2, 433-439
13. Wu, H., Pfarr, D. S., Losonsky, G. A., and Kiener, P. A. (2008) Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab. Curr. Top, Microbiol, Immunol. 317, 103-123
14. Collins, P. L., and Melero, J. A. (2011) Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 162, 80-99
15. Hall, C. B., Long, C. E., and Schnabel, K. C. (2001) Respiratory syncytial virus infections in previously healthy working adults. Clin. Infect. Dis. 33, 792-796
16. Barik, S. (2013) Respiratory syncytial virus mechanisms to interfere with type 1 interferons. Curr. Top. Microbiol. Immunol. 372, 173-191
17. Glezen, W. P., Taber, L. H., Frank, A. L., and Kasel, J. A. (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Children 140, 543-546
18. Janssen, R., Pennings, J., Hodemaekers, H., Buisman, A., van Oosten, M., de Rond, L., Ozturk, K., Dormans, J., Kimman, T., and Hoebee, B. (2007) Host transcription profiles upon primary respiratory syncytial virus infection. J. Virol. 81, 5958-5967
19. Martinez, I., Lombardia, L., Garcia-Barreno, B., Dominguez, O., and Melero, J. A. (2007) Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. J. Gen. Virol. 88, 570-581
20. Mayer, A. K., Muehmer, M., Mages, J., Gueinzius, K., Hess, C., Heeg, K., Bals, R., Lang, R., and Dalpke, A. H. (2007) Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J. Immunol. 178, 3134-3142
21. Tian, B., Zhang, Y., Luxon, B. A., Garofalo, R. P., Casola, A., Sinha, M., and Brasier, A. R. (2002) Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells. J. Virol. 76, 6800-6814
22. Zhang, Y., Luxon, B. A., Casola, A., Garofalo, R. P., Jamaluddin, M., and Brasier, A. R. (2001) Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J. Virol. 75, 9044-9058
23. Brasier, A. R., Spratt, H., Wu, Z., Boldogh, I., Zhang, Y., Garofalo, R. P., Casola, A., Pashmi, J., Haag, A., Luxon, B., and Kurosky, A. (2004) Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresis. J. Virol. 78, 11461-11476
24. Hastie, M. L., Headlam, M. J., Patel, N. B., Bukreyev, A. A., Buchholz, U. J., Dave, K. A., Norris, E. L., Wright, C. L., Spann, K. M., Collins, P. L., and Gorman, J. J. (2012) The human respiratory syncytial virus nonstructural protein 1 regulates type I and type II interferon pathways. Mol. Cell. Proteomics 11, 108-127
25. Jamaluddin, M., Wiktorowicz, J. E., Soman, K. V., Boldogh, I., Forbus, J. D., Spratt, H., Garofalo, R. P., and Brasier, A. R. (2010) Role of peroxiredoxin 1 and peroxiredoxin 4 in protection of respiratory syncytial virus-induced cysteinyl oxidation of nuclear cytoskeletal proteins. J. Virol. 84, 9533-9545
26. Munday, D. C., Emmott, E., Surtees, R., Lardeau, C. H., Wu, W., Duprex, W. P., Dove, B. K., Barr, J. N., and Hiscox, J. A. (2010) Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus. Mol. Cell. Proteomics 9, 2438-2459
27. Munday, D. C., Surtees, R., Emmott, E., Dove, B. K., Digard, P., Barr, J. N., Whitehouse, A., Matthews, D., and Hiscox, J. A. (2012) Using SILAC and quantitative proteomics to investigate the interactions between viral and host proteomes. Proteomics 12, 666-672
28. Ternette, N., Wright, C., Kramer, H. B., Altun, M., and Kessler, B. M. (2011) Label-free quantitative proteomics reveals regulation of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) and 5′-3′-exoribonuclease 2 (XRN2) during respiratory syncytial virus infection. Virol. J. 8, 442
29. van Diepen, A., Brand, H. K., Sama, I., Lambooy, L. H., van den Heuvel, L. P., van der Well, L., Huynen, M., Osterhaus, A. D., Andeweg, A. C., and Hermans, P. W. Quantitative proteome profiling of respiratory virusinfected lung epithelial cells. J. Proteomics 73, 1680-1693
30. Collins, P. L., Fearns, R., and Graham, B. S. (2013) Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Curr. Top. Microbiol. 372, 3-38
31. Spann, K. M., Tran, K. C., Chi, B., Rabin, R. L., and Collins, P. L. (2004) Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J. Virol. 78, 4363-4369
32. Munir, S., Le Nouen, C., Luongo, C., Buchholz, U. J., Collins, P. L., and Bukreyev, A. (2008) Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. J. Virol. 82, 8780-8796
33. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372
34. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., and Mann, M. (2011) Andromeda: A peptide search engine integrated into the maxquant environment. J. Proteome Res. 10, 1794-1805
35. Nesvizhskii, A. I., and Aebersold, R. (2005) Interpretation of shotgun proteomic data: the protein inference problem. Mol. Cell. Proteomics 4, 1419-1440
36. Anders, S., and Huber, W. (2010) Differential expression analysis for sequence count data. Genome Biol. 11, R106
37. Wang, P., Tang, H., Zhang, H., Whiteaker, J., Paulovich, A. G., and McIntosh, M. (2013) Normalization regarding nonrandom missing values in high-throughput mass spectrometry data. Mol Cell Proteomics, 12(3), 549-556
38. Robinson, M. D., McCarthy, D. J., and Smyth, G. K. (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140
39. Robinson, M. D., and Smyth, G. K. (2007) Moderated statistical tests for assessing differences in tag abundance. Bioinformatics 23, 2881-2887
40. Robinson, M. D., and Smyth, G. K. (2008) Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics 9, 321-332
41. R Core Team (2012) R: A language and environment for statistical computing. 2.15.1 Ed., R Foundation for Statistical Computing, Vienna, Austria.
42. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B. 57, 289-300
43. Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A., and Vingron, M. (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18, S96-S104
44. Karp, N. A., Huber, W., Sadowski, P. G., Charles, P. D., Hester, S. V., and Lilley, K. S. (2010) Addressing accuracy and precision issues in iTRAQ quantitation. Mol. Cell. Proteomics 9, 1885-1897
45. Smyth, G. K. (2013) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Mol Cell Proteomics. 12(3), 825-831
46. Smyth, G. K. (2013) Limma: Linear models for microarray data. Mol Cell Proteomics. 12(6), 1502-1512
47. Silva, J. C., Gorenstein, M. V., Li, G. Z., Vissers, J. P., and Geromanos, S. J. (2006) Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol. Cell. Proteomics 5, 144-156
48. Gregory R. Warnes. Includes R source code and/or documentation contributed by: Ben Bolker, L. B., Robert Gentleman, Wolfgang Huber, Andy Liaw, Thomas Lumley, Martin Maechler, Arni Magnusson, Steffen Moeller, Marc Schwartz & Bill Venables (2012) gplots: Various R programming tools for plotting data.
49. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald, M., Rubin, G. M., Sherlock, G., and Gene Ontology, C. (2000) Gene Ontology: tool for the unification of biology. Nat. Genetics 25, 25-29
50. Blake, J. A., Dolan, M., Drabkin, H., Hill, D. P., Ni, L., Sitnikov, D., Burgess, S., Buza, T., Gresham, C., McCarthy, F., Pillai, L., Wang, H., Carbon, S., Lewis, S. E., Mungall, C. J., Gaudet, P., Chisholm, R. L., Fey, P., Kibbe, W. A., Basu, S., Siegele, D. A., McIntosh, B. K., Renfro, D. P., Zweifel, A. E., Hu, J. C., Brown, N. H., Tweedie, S., Alam-Faruque, Y., Apweiler, R., Auchinchloss, A., Axelsen, K., Argoud-Puy, G., Bely, B., Blatter, M. C., Bougueleret, L., Boutet, E., Branconi-Quintaje, S., Breuza, L., Bridge, A., Browne, P., Chan, W. M., Coudert, E., Cusin, I., Dimmer, E., Duek-Roggli, P., Eberhardt, R., Estreicher, A., Famiglietti, L., Ferro- Rojas, S., Feuermann, M., Gardner, M., Gos, A., Gruaz-Gumowski, N., Hinz, U., Hulo, C., Huntley, R., James, J., Jimenez, S., Jungo, F., Keller, G., Laiho, K., Legge, D., Lemercier, P., Lieberherr, D., Magrane, M., Martin, M. J., Masson, P., Moinat, M., O'Donovan, C., Pedruzzi, I., Pichler, K., Poggioli, D., Millan, P. P., Poux, S., Rivoire, C., Roechert, B., Sawford, T., Schneider, M., Sehra, H., Stanley, E., Stutz, A., Sundaram, S., Tognolli, M., Xenarios, I., Foulger, R., Lomax, J., Roncaglia, P., Camon, E., Khodiyar, V. K., Lovering, R. C., Talmud, P. J., Chibucos, M., Giglio, M. G., Dolinski, K., Heinicke, S., Livstone, M. S., Stephan, R., Harris, M. A., Oliver, S. G., Rutherford, K., Wood, V., Bahler, J., Lock, A., Kersey, P. J., McDowall, M. D., Staines, D. M., Dwinell, M., Shimoyama, M., Laulederkind, S., Hayman, T., Wang, S. J., Petri, V., Lowry, T., D'Eustachio, P., Matthews, L., Amundsen, C. D., Balakrishnan, R., Binkley, G., Cherry, J. M., Christie, K. R., Costanzo, M. C., Dwight, S. S., Engel, S. R., Fisk, D. G., Hirschman, J. E., Hitz, B. C., Hong, E. L., Karra, K., Krieger, C. J., Miyasato, S. R., Nash, R. S., Park, J., Skrzypek, M. S., Weng, S., Wong, E. D., Berardini, T. Z., Li, D., Huala, E., Slonim, D., Wick, H., Thomas, P., Chan, J., Kishore, R., Sternberg, P., Van Auken, K., Howe, D., Westerfield, M., and Gene Ontology, C. (2012) The Gene Ontology: enhancements for 2011. Nucleic Acids Res. 40, D559-D564
51. Binns, D., Dimmer, E., Huntley, R., Barrell, D., O'Donovan, C., and Apweiler, R. (2009) QuickGO: a web-based tool for Gene Ontology searching. Bioinformatics 25, 3045-3046
52. Rusinova, I., Forster, S., Yu, S., Kannan, A., Masse, M., Cumming, H., Chapman, R., and Hertzog, P. J. (2013) INTERFEROME v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 41, D1040-D1046
53. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., and Ideker, T. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504
54. Fleckner, J., Martensen, P. M., Tolstrup, A. B., Kjeldgaard, N. O., and Justesen, J. (1995) Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 7, 70-77
55. Chung-man Ho, J., Zheng, S., Comhair, S. A., Farver, C., and Erzurum, S. C. (2001) Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res. 61, 8578-8585
56. Harris, C. A., Derbin, K. S., Hunte-McDonough, B., Krauss, M. R., Chen, K. T., Smith, D. M., and Epstein, L. B. (1991) Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types. Synergistic induction by IFN-gamma and tumor necrosis factor or IL-1. J. Immunol. 147, 149-154
57. Sanda, C., Weitzel, P., Tsukahara, T., Schaley, J., Edenberg, H. J., Stephens, M. A., McClintick, J. N., Blatt, L. M., Li, L., Brodsky, L., and Taylor, M. W. (2006) Differential gene induction by type I and type II interferons and their combination. J. Interferon Cytokine Res. 26, 462-472
58. Rogers, R. J., Monnier, J. M., and Nick, H. S. (2001) Tumor necrosis factor-alpha selectively induces MnSOD expression via mitochondria-tonucleus signaling, whereas interleukin-1beta utilizes an alternative pathway. J. Biol. Chem. 276, 20419-20427
59. Sana, T. R., Janatpour, M. J., Sathe, M., McEvoy, L. M., and McClanahan, T. K. (2005) Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 29, 256-269
60. Warner, B. B., Burhans, M. S., Clark, J. C., and Wispe, J. R. (1991) Tumor necrosis factor-alpha increases Mn-SOD expression: protection against oxidant injury. Am. J. Physiol. 260, L296-L301
61. Wong, G. H., and Goeddel, D. V. (1988) Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242, 941-944
62. Lu, G., Shimizu, I., Cui, X., Itonaga, M., Tamaki, K., Fukuno, H., Inoue, H., Honda, H., and Ito, S. (2002) Interferon-alpha enhances biological defense activities against oxidative stress in cultured rat hepatocytes and hepatic stellate cells. J. Med. Invest. 49, 172-181
63. Bayardo, M., Punzi, F., Bondar, C., Chopita, N., and Chirdo, F. (2012) Transglutaminase 2 expression is enhanced synergistically by interferongamma and tumour necrosis factor-alpha in human small intestine. Clin. Exp, Immunol. 168, 95-104
64. Kim, S. Y., Jeong, E. J., and Steinert, P. M. (2002) IFN-gamma induces transglutaminase 2 expression in rat small intestinal cells. J. Interferon Cytokine Res. 22, 677-682
65. Chen, Y. Y., Chambers, M. C., Li, M., Ham, A. J., Turner, J. L., Zhang, B., and Tabb, D. L. (2013) IDPQuantify: combining precursor intensity with spectral counts for protein and peptide quantification. J. Proteome Res. 12, 4111-4121
66. Old, W. M., Meyer-Arendt, K., Aveline-Wolf, L., Pierce, K. G., Mendoza, A., Sevinsky, J. R., Resing, K. A., and Ahn, N. G. (2005) Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol. Cell. Proteomics 4, 1487-1502
67. Gorman, J. J., Ferguson, B. L., Speelman, D., and Mills, J. (1997) Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Protein Sci. 6, 1308-1315
68. Fensterl, V., and Sen, G. C. (2009) Interferons and viral infections. BioFactors 35, 14-20
69. Sharma, M., Sharma, S., Roy, S., Varma, S., and Bose, M. (2007) Pulmonary epithelial cells are a source of interferon-gamma in response to Mycobacterium tuberculosis infection. Immunol. Cell Biol. 85, 229-237
70. Choudhary, S., Boldogh, S., Garofalo, R., Jamaluddin, M., and Brasier, A. R. (2005) Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2. J. Virol. 79, 8948-8959
71. Dou, Y., Zhao, Y., Zhang, Z. Y., Mao, H. W., Tu, W. W., and Zhao, X. D. (2013) Respiratory syncytial virus infection induces higher Toll-like receptor-3 expression and TNF-alpha production than human metapneumovirus infection. PloS One 8, e73488
72. Spann, K. M., Tran, K. C., and Collins, P. L. (2005) Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J. Virol. 79, 5353-5362
73. Bossert, B., Marozin, S., and Conzelmann, K. K. (2003) Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J. Virol. 77, 8661-8668
74. Kotelkin, A., Belyakov, I. M., Yang, L., Berzofsky, J. A., Collins, P. L., and Bukreyev, A. (2006) The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response. J. Virol. 80, 5958-5967
75. Ling, Z., Tran, K. C., and Teng, M. N. (2009) Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J. Virol. 83, 3734-3742
76. Lo, M. S., Brazas, R. M., and Holtzman, M. J. (2005) Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79, 9315-9319
77. Ramaswamy, M., Shi, L., Varga, S. M., Barik, S., Behlke, M. A., and Look, D. C. (2006) Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344, 328-339
78. Schlender, J., Bossert, B., Buchholz, U., and Conzelmann, K. K. (2000) Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J. Virol. 74, 8234-8242
79. Swedan, S., Musiyenko, A., and Barik, S. (2009) Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways. J. Virol. 83, 9682-9693
80. Elliott, J., Lynch, O. T., Suessmuth, Y., Qian, P., Boyd, C. R., Burrows, J. F., Buick, R., Stevenson, N. J., Touzelet, O., Gadina, M., Power, U. F., and Johnston, J. A. (2007) Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J. Virol. 81, 3428-3436
81. Smith, L. M., Kelleher, N. L., and Consortium for Top Down, P. (2013) Proteoform: a single term describing protein complexity. Nat.Methods 10, 186-187